GPR183 and multiple sclerosis: EBI2 has been reported to enhance immune cell migration to accelerate the development of multiple sclerosis.[16] However, we surprisingly observed that the numbers of immune cells were robustly increased in the peritoneal cavity of Ebi2‐cKO mice upon TMPD administration (Figure 6E).